HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interim AHA Labeling Guidance Proposed By FDA Pending NTP Study Results

This article was originally published in The Rose Sheet

Executive Summary

FDA's draft guidance for labeling of alpha hydroxy acid-containing products is an interim step taken while the agency continues to evaluate AHAs and their impact on increased skin sensitivity to the sun, FDA says in a Dec. 2 1Federal Register notice

You may also be interested in...



FDA Final Guidance On AHAs Clarifies “Sunburn Alert” Labeling

FDA is modifying recommendations for which alpha hydroxy acid-containing cosmetics should carry "Sunburn Alert" labeling to include products that may be applied unintentionally to areas of the body that are exposed to sun, such as those that contain fragrance ingredients, humectants and skin conditioning agents

FDA Final Guidance On AHAs Clarifies “Sunburn Alert” Labeling

FDA is modifying recommendations for which alpha hydroxy acid-containing cosmetics should carry "Sunburn Alert" labeling to include products that may be applied unintentionally to areas of the body that are exposed to sun, such as those that contain fragrance ingredients, humectants and skin conditioning agents

AHA, BHA Products Are Cosmetics Based On Legal Precedent – CTFA

FDA should not address cosmetic compliance issues by reclassifying entire categories of products as drugs, the Cosmetic, Toiletry and Fragrance Association asserts in comments to the agency

Related Content

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel